Atlas Biomed Group

Atlas Biomed Group is a United Kingdom based startup that leverages cutting-edge genetic technologies to offer personalized health solutions. Founded in 2016, the company's focus is on empowering individuals to make informed decisions about their health by providing insights into carrier status, hereditary ailments, nutrient levels, and intolerances. Additionally, Atlas Biomed offers personalized reports on DNA ancestry, probiotics, dietary fiber breakdown, butyrate synthesis, and personalized food recommendations.

With a recent $13.00M Series B investment in November 2020, the company has garnered attention from potential investors. Atlas Biomed's mission of promoting healthy lifestyle changes through genetic technologies has aligned with the growing demand for personalized health and wellness solutions in the biotechnology, healthcare, and nutrition industries. This investment signifies confidence in the company's capabilities to guide and equip customers for a healthier future.

Strategically positioned at the intersection of technology and healthcare, Atlas Biomed is well poised to capitalize on the increasing trend towards personalized health and wellness solutions. The company's unique offering and recent investment make it a compelling prospect for venture capitalists seeking opportunities in the rapidly evolving biotechnology and healthcare sectors.